Vivos Therapeutics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Vivos Therapeutics, Inc. (VVOS) reported Adjustments to Additional Paid in Capital, Warrant Issued of $31.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-04-15
- Vivos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-09-30 was $6.00K, a 96.15% decline year-over-year.
- Vivos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-06-30 was $11.00K, a 93.96% decline year-over-year.
- Vivos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-03-31 was $6.00K, a 99.04% decline year-over-year.
- Vivos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-09-30 was $156.00K.
- Vivos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $31.00K.
- Vivos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $711.00K, a 206.47% increase from fiscal 2021.
- Vivos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $232.00K, a 84.84% decline from fiscal 2020.
- Vivos Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $1.53M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2024-12-31 | $31.00K 10-K · filed 2026-04-15 | |||
| 2024-09-30 | $6.00K 10-Q · filed 2025-11-19 | $17.00K derived: sum of 2 quarters · filed 2025-11-19 | $23.00K derived: sum of 3 quarters · filed 2025-11-19 | |
| 2024-06-30 | $11.00K 10-Q · filed 2025-11-19 | $17.00K derived: sum of 2 quarters · filed 2025-11-19 | ||
| 2024-03-31 | $6.00K 10-Q · filed 2025-11-19 | |||
| 2023-09-30 | $156.00K 10-Q · filed 2024-11-14 | $338.00K derived: sum of 2 quarters · filed 2024-11-14 | $963.00K derived: sum of 3 quarters · filed 2024-11-14 | |
| 2023-06-30 | $182.00K 10-Q · filed 2024-11-14 | $807.00K derived: sum of 2 quarters · filed 2024-11-14 | ||
| 2023-03-31 | $625.00K 10-Q · filed 2024-11-14 | |||
| 2022-12-31 | $711.00K 10-K/A · filed 2024-07-30 | |||
| 2021-12-31 | $232.00K 10-K · filed 2023-03-30 | |||
| 2021-03-31 | $136.33K 10-Q · filed 2021-11-15 | |||
| 2020-12-31 | $1.53M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |